Important notice regarding Rhopressa

Posted in Latest News on February 12, 2019.

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa.



More Latest News

Board Chairs/Vice Chairs Annual Long-range Planning Meeting
June 12, 2019

The Annual Long Range Planning meeting has been scheduled for Friday, October 18, 2019. Please click here for more information. Continue reading


New Legislation Impacting Your Profession
May 16, 2019

Click here to view a full list of bill summaries from the 2019 Florida Legislative Session that may impact your profession. Continue reading